PAR 2.56% 20.0¢ paradigm biopharmaceuticals limited..

Chart, page-4030

  1. 1,216 Posts.
    lightbulb Created with Sketch. 1375
    Not sure. Whoever it is, they've been hitting us since April. No evidence of someone selling out. No evidence of short selling. My theory is, as unlikely as it is, that one of our competitors have taken out contracts with various trading rooms to keep our SP suppressed to try to slow down or halt our P3 program. Just a theory with zero evidence.

    Or it could simply be the targeting of the biotech sector in general, who knows.
    Last edited by Zenox: 11/10/23
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.